Case Studies
[accordion collapsed]
Matracell Processing Technology
.png)
DECELLULARIZATION
The Matracell process — utilized in cardiovascular and dermal allografts — yields a strong, acellular scaffold that facilitates cell proliferation, cell migration and vascularization. Only tissue processed with Matracell technology meets the threshold of being truly decellularized, minimizing the possibility of an immune response.
VertiGraft Clinical Review
Clinical Reports using VertiGraft in Cervical ACDF
Abla A, El Kadi H, Bost J, Maroon J, and Wert M. Allograft Composite Cortical and Cancellous Bone Graft for Anterior Cerival Fusion.Contemporary Neurosurgery: A Biweekly Publication for Clinical Neurosurgical Continuing Medical Education. 2005;27(8):1-6.
ViviGen Clinical Review
There is a growing body of clinical evidence supporting ViviGen and ViviGen Formable cellular bone matrix, including recent data that shows effective multi-level fusion even in challenging cases.
Special Events
.jpg)
ASK THE EXPERT,
TECHNICAL Q&A WITH MARK MOORE, PH.D.
WEDNESDAY, SEPTEMBER 25 10AM & 3PM
THURSDAY, SEPTEMBER 26 10AM & 3PM
EXPERIENCE PERFORMANCE THAT STANDS OUT
AT OUR HANDLING STATION IN NASS BOOTH 4024
PliaFX® Prime
The world’s most versatile osteobiologic.
Many commercial DBMs utilize an inert carrier to improve handling, and the proportion of demineralized bone content in the graft varies widely by manufacturer.
ViviGen® and ViviGen Formable®
The first cellular allograft to focus on recovering, processing, and protecting viable, lineage committed bone cells. It is comprised of viable, cryopreserved corticocancellous bone matrix and demineralized bone.
ViviGen represents a paradigm shift in the field of bone repair and tissue engineering by focusing on lineage committed bone cells.